美國導管導引線市場規模、佔有率和趨勢分析報告：產品和細分市場預測（2025-2033 年）

美國導管導引線市場摘要

2024年美國導管導引線市場規模估計為8.306億美元，預計2033年將達到12.743億美元。

預計從 2025 年到 2033 年，該市場將以 4.87% 的複合年成長率成長。泌尿系統疾病、心血管疾病和周邊動脈疾病(PAD) 的日益普遍是市場成長的主要促進因素。

此外，微創手術的興起以及人口老化加劇，為產品需求的成長提供了機會。冠狀動脈和周邊血管介入手術的增加以及人口老化等因素正在推動國內對微創手術的需求，預計這將在未來幾年對市場產生積極影響。在美國，由於侵入性手術感染風險較高，大多數患者選擇非侵入性手術。根據耶魯大學醫學院公佈的數據，美國每年約進行90萬例經皮冠狀動脈介入治療（PCI）。如此龐大的手術量預計將支撐全國對導管導引線的需求。

此外，旨在拓展導管導引線應用範圍的臨床試驗和研究數量不斷成長，預計將顯著推動該國市場成長。這些研究日益著重於評估導管導引線在各種手術中的安全性和有效性，並促進新型先進產品的研發。研究機構、學術中心和產業相關人員正積極參與這些研究。積極的臨床結果驗證了產品的性能，有助於獲得監管部門的核准，並提高臨床醫生的使用率，從而進一步促進市場擴張。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章美國導管導引線市場變數、趨勢與範圍

• 市場譜系展望
  • 母市場展望
• 市場動態
• 美國導管導引線市場分析工具
  • 波特分析
  • PESTEL 分析

第4章：美國導管導引線市場：依產品分類的估算與趨勢分析

• 美國導管導引線市場產品波動分析
• 美國導管導引線市場規模及趨勢分析（依產品分類，2021-2033 年）
• 冠狀動脈導管導引線
• 末梢血管導管導引線
• 泌尿系統導管導引線
• 神經血管導管導引線

第5章 競爭情勢

• 對主要市場參與企業近期趨勢和影響的分析
• 公司/競爭對手分類
  • 創新者
• 供應商概況
  • 主要經銷商和通路夥伴
  • Key customers
  • US key company market share analysis, 2024
  • Boston Scientific Corporation
  • Medtronic
  • Cook
  • Terumo Medical Corporation
  • Abbott
  • Stryker
  • Teleflex Incorporated
  • BD
  • ASAHI INTECC USA, INC.
  • Olympus America
  • Dornier MedTech.
  • Koninklijke Philips NV
• 熱力圖分析/企業市場分析
• 2024年企業市場占有率預測分析
• 其他主要市場參與者名單

U.S. Guidewires Market Summary

The U.S. guidewires market size was estimated at USD 830.6 million in 2024 and is projected to reach USD 1,274.3 million by 2033, growing at a CAGR of 4.87% from 2025 to 2033. The increasing prevalence of urological disorders, cardiovascular diseases, and Peripheral Artery Disease (PAD) is significantly driving the growth of the market.

Moreover, a growing number of minimally invasive surgeries, paired with a rising geriatric population, presents an opportunity for increased product demand. Factors such as a rising number of coronary & peripheral intervention procedures and an increase in the geriatric population are resulting in high demand for minimally invasive surgeries in the country. This is expected to have a positive impact on the market in the years to come. A majority of people in the U.S. are inclined towards noninvasive surgeries owing to the probability of high infection associated with invasive procedures. According to data published by Yale Medicine, approximately 900,000 percutaneous coronary interventions (PCIs) are performed in the U.S. every year. Thus, such a high procedural volume is anticipated to support the nationwide demand for guidewires.

Moreover, the rising number of clinical trials and research studies aimed at expanding the applications of guidewires is expected to significantly support the country's market growth. These trials are increasingly focused on assessing the safety and efficacy of guidewires across various procedures, as well as accelerating the development of novel and advanced products. Research institutions, academic centers, and industry players are actively collaborating on these investigations. Favorable clinical outcomes validate product performance, facilitating regulatory approvals, enhancing clinician adoption, and contributing to broader market expansion.

U.S. Guidewires Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. guidewires market report based on product:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Coronary Guidewires
  • Peripheral Guidewires
  • Urology Guidewires
  • Neurovascular Guidewires

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Guidewires Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increased Prevalence of Chronic Diseases
    • 3.2.1.2. Advancements in Medical Technology
    • 3.2.1.3. Increasing Preference for Minimally Invasive Procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Alternative Treatment Options
    • 3.2.2.2. Stringent Regulatory Requirements
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Supportive Government Initiatives
    • 3.2.3.2. Rising Clinical Studies and Trials
    • 3.2.3.3. Growing Expansion of Healthcare Infrastructure
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Product Recalls
    • 3.2.4.2. Potential Risks And Complications
• 3.3. U.S. Guidewires Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Guidewires Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Guidewires Market Product Movement Analysis
• 4.3. U.S. Guidewires Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Coronary Guidewires
  • 4.4.1. Coronary Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Peripheral Guidewires
  • 4.5.1. Peripheral Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.6. Urology Guidewires
  • 4.6.1. Urology Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.7. Neurovascular Guidewires
  • 4.7.1. Neurovascular Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Recent Developments & Impact Analysis, By Key Market Participants
• 5.2. Company/Competition Categorization
  • 5.2.1. Innovators
• 5.3. Vendor Landscape
  • 5.3.1. List of key distributors and channel partners
  • 5.3.2. Key customers
  • 5.3.3. U.S. key company market share analysis, 2024
  • 5.3.4. Boston Scientific Corporation
    • 5.3.4.1. Company overview
    • 5.3.4.2. Financial performance
    • 5.3.4.3. Product benchmarking
    • 5.3.4.4. Strategic initiatives
  • 5.3.5. Medtronic
    • 5.3.5.1. Company overview
    • 5.3.5.2. Financial performance
    • 5.3.5.3. Product benchmarking
    • 5.3.5.4. Strategic initiatives
  • 5.3.6. Cook
    • 5.3.6.1. Company overview
    • 5.3.6.2. Financial performance
    • 5.3.6.3. Product benchmarking
    • 5.3.6.4. Strategic initiatives
  • 5.3.7. Terumo Medical Corporation
    • 5.3.7.1. Company overview
    • 5.3.7.2. Financial performance
    • 5.3.7.3. Product benchmarking
    • 5.3.7.4. Strategic initiatives
  • 5.3.8. Abbott
    • 5.3.8.1. Company overview
    • 5.3.8.2. Financial performance
    • 5.3.8.3. Product benchmarking
    • 5.3.8.4. Strategic initiatives
  • 5.3.9. Stryker
    • 5.3.9.1. Company overview
    • 5.3.9.2. Financial performance
    • 5.3.9.3. Product benchmarking
    • 5.3.9.4. Strategic initiatives
  • 5.3.10. Teleflex Incorporated
    • 5.3.10.1. Company overview
    • 5.3.10.2. Financial performance
    • 5.3.10.3. Product benchmarking
    • 5.3.10.4. Strategic initiatives
  • 5.3.11. BD
    • 5.3.11.1. Company overview
    • 5.3.11.2. Financial performance
    • 5.3.11.3. Product benchmarking
    • 5.3.11.4. Strategic initiatives
  • 5.3.12. ASAHI INTECC USA, INC.
    • 5.3.12.1. Company overview
    • 5.3.12.2. Financial performance
    • 5.3.12.3. Product benchmarking
    • 5.3.12.4. Strategic initiatives
  • 5.3.13. Olympus America
    • 5.3.13.1. Company overview
    • 5.3.13.2. Financial performance
    • 5.3.13.3. Product benchmarking
    • 5.3.13.4. Strategic initiatives
  • 5.3.14. Dornier MedTech.
    • 5.3.14.1. Company overview
    • 5.3.14.2. Financial performance
    • 5.3.14.3. Product benchmarking
    • 5.3.14.4. Strategic initiatives
  • 5.3.15. Koninklijke Philips N.V.
    • 5.3.15.1. Company overview
    • 5.3.15.2. Financial performance
    • 5.3.15.3. Product benchmarking
    • 5.3.15.4. Strategic initiatives
• 5.4. Heat Map Analysis/ Company Market Position Analysis
• 5.5. Estimated Company Market Share Analysis, 2024
• 5.6. List of Other Key Market Players

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. guidewires market, by product, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Guidewires Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 U.S. Guidewires Market, for Product, 2021 - 2033 (USD Million)
• Fig. 14 U.S. Guidewires Market, for Coronary Guidewires, 2021 - 2033 (USD Million)
• Fig. 15 U.S. Guidewires Market, for Peripheral Guidewires, 2021 - 2033 (USD Million)
• Fig. 16 U.S. Guidewires Market, for Urology Guidewires, 2021 - 2033 (USD Million)
• Fig. 17 U.S. Guidewires Market, for Neurovascular Guidewires, 2021 - 2033 (USD Million)